Navigation Links
Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
Date:6/16/2008

NEW ORLEANS, June 16 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced that it will now manufacture, compound and distribute Positron Emission Tomography (PET) radiopharmaceuticals for clinical trials.

The company's new services for the clinical trial market will be discussed at the Society of Nuclear Medicine's (SNM) 55th Annual Meeting, taking place in New Orleans, June 14-18.

Cardinal Health owns and operates a network of more than 150 nuclear pharmacies and operates 25 cyclotron-based PET radiopharmaceutical manufacturing facilities. These facilities are registered with the Food and Drug Administration (FDA) to manufacture PET radiopharmaceuticals that are used by physicians to diagnose various medical conditions.

The company will now offer its PET manufacturing and distribution services to support clinical trials of new and novel PET agents. Cardinal Health will also work with pharmaceutical companies and physicians interested in using PET products to determine the efficacy of therapeutic medications.

"We're committed to advancing the future of molecular imaging by helping manufacturers expand the pipeline of new agents that will aid in the diagnosis and treatment of disease," said John Rademacher, general manager of nuclear pharmacy services for Cardinal Health. "By supporting the clinical trial phase of PET drug development, we will also build strong, long-term partnerships as these products move through the testing and approval phase and into routine clinical application."

As part of its comprehensive service, Cardinal Health will also submit drug master files to the FDA for several of the PET agents it manufactures. These files contain detailed information about the manufacturing and storing of a specific drug and can help expand the use of PET products because they allow physicians and others in the pharmace
'/>"/>

SOURCE Cardinal Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
2. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
3. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
4. Cardinal Health Completes Enturia Acquisition
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
7. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Tone Deafness Explained, from the Harvard Health Letter
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014   Auxilium Pharmaceuticals ... integrated specialty biopharmaceutical company, today announced that the Company ... on Thursday, August 7, 2014 before the opening of ... a conference call that day at 8:30 a.m. ET ... of 2014. The presentation slides to be used during ...
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 /PRNewswire/ ... committee members—who make decisions about which therapies are ... influence formulary placement, according to a new Manhattan ... Makers 2014 . The study finds that P&T ... and pharmacy benefits managers (PBMs) have set a ...
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2
(Date:7/31/2014)... 31, 2014 The vineyards are lush, and ... harvest. And, to celebrate, folks are gearing up for the ... 6 and 7, 2014 along the Leelanau Peninsula Wine ... walk or run through the vineyards start-ing at 9:00 a.m. ... A unique course between rows of grapevines offers an experience ...
(Date:7/31/2014)... United Theological Seminary is pleased to welcome ... and Peter J. Bellini. Both began their teaching duties ... a Director of Non-Degree Programs, Mark Abbott, who begins ... Donne, Assistant Professor of New Testament, received a Ph.D. ... Second Temple Judaism, and Greek courses. His research interests ...
(Date:7/31/2014)... Miami, FL (PRWEB) July 31, 2014 ... Guinness International Champions Cup Finals tickets at the Sun ... 2014 Guinness International Champions Cup is now underway. Residents and ... to be able to watch the Guinness International Champions Cup ... The eight teams competing in the tournament have been split ...
(Date:7/31/2014)... Denver, Colorado (PRWEB) July 31, 2014 ... commonly doctors recommend pain killers for this health problem. ... reveals that this new program was created by Peter ... purpose to help sufferers from all over the world ... , If people wish to view pros and ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Andrie, Inc. V. ... , The Michigan Supreme Court has made the determination that ... use tax when the taxpayer was unable to prove during ... purchases. The Court reversed the Court of Appeals decision on ... the use tax exemption for purchases from Michigan sellers. The ...
Breaking Medicine News(10 mins):Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2Health News:Growing Seminary Welcomes New Faculty 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 3Health News:Neuropathy Miracle Review Reveals Peter Bansby's Unique Cure Method 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3
... another bout of West Nile, a potentially fatal, mosquito-spread infection. ... Control of the Harris county has said that the situation ... is still a large percentage of people in Houston who ... repellants or going out at night in short-sleeve shirts can ...
... out with the report that with UK leading the group, cancer ... use of new drugs. ,The study termed uptake of ... as well as in New Zealand, Poland, Czech Republic and South ... US were leaders in using new cancer drugs. ,The ...
... forty per cent (37 per cent) of British women and a ... unattractive on holiday as a result of excessive exposure to the ... has been conducted to highlight Sun Awareness Week, which kicks off ... over unsightly sunburn has meant that one in three Brits could ...
... eyes, say experts, who advise frequent short breaks every half ... ,Studies have shown that eyestrain and other vision problems ... people using video display terminals at work, said Kerry Beebe, ... ,The most common symptoms are eyestrain, blurred vision, ...
... the brakes on a racing heartbeat. ... the May 11 issue of Circulation Research how an enzyme ... of the heart's "fight-or-flight" reaction to adrenaline. ,A ... setting the pace of the beating heart, triggering its neighbor ...
... who is on a visit to the US, has ... in Hyderabad, promising to provide all necessary infrastructure. ... the signing of an MoU between Stanford University, the ... Research Institute) in California Thursday. ,Under the ...
Cached Medicine News:Health News:Health Authorities Fear West Nile Season Again in US 2Health News:Britains Complacent Attitude To Uptake Of New Cancer Drugs Revealed 2Health News:Burnt Brits Don't Feel Hot 2Health News:Many Hours on Computer may Harm Eyes 2Health News:Slowing the Racing Heart 2Health News:Reddy Asks Stanford University to Open Hyderabad Campus 2
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Inorganic phosphorus (UV method) reagent is for the quantitative determination of inorganic phosphorus in human serum....
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
Medicine Products: